ADAM metallopeptidase domain 10 ; Homo sapiens






215 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 10818225 The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 2000 May 19 1
2 11000516 The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone. Mol Cell Endocrinol 2000 Sep 25 1
3 11309494 Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A 2001 May 8 4
4 11334139 ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes. Antisense Nucleic Acid Drug Dev 2001 Apr 1
5 11477090 The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 2001 Oct 12 4
6 12475894 ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 2003 Feb 1
7 12714508 The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003 Aug 15 4
8 12755693 Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. Eur J Biochem 2003 Jun 1
9 12832423 Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J Biol Chem 2003 Oct 3 2
10 14713188 Modeling of enzyme-substrate complexes for the metalloproteases MMP-3, ADAM-9 and ADAM-10. J Comput Aided Mol Des 2003 Sep 1
11 14734484 Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clin Cancer Res 2004 Jan 1 3
12 15182369 The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein. Eur J Biochem 2004 Jun 2
13 15341532 Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines. J Neurochem 2004 Sep 3
14 15777180 Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 2005 Mar 4
15 15972296 Genomic structure and functional characterization of the human ADAM10 promoter. FASEB J 2005 Sep 1
16 16229685 A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J 2006 Feb 1 2
17 16239146 Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 2005 Oct 21 1
18 16309826 Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Lett 2007 Jan 8 2
19 16687212 Characterization of sequential N-cadherin cleavage by ADAM10 and PS1. Neurosci Lett 2006 Jul 24 1
20 16735514 ADAM10-mediated release of complement membrane cofactor protein during apoptosis of epithelial cells. J Biol Chem 2006 Jul 28 1
21 17047365 Alpha-secretase activation--an approach to Alzheimer's disease therapy. Neurodegener Dis 2006 1
22 17079736 Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol Biol Cell 2007 Jan 1
23 17428795 Ligand binding and calcium influx induce distinct ectodomain/gamma-secretase-processing pathways of EphB2 receptor. J Biol Chem 2007 Jun 1 2
24 17548045 Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening. Anal Biochem 2007 Jul 15 9
25 17548644 Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol 2007 Jun 15 1
26 17650113 New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing alpha-secretase activity. Eur J Neurosci 2007 Jul 1
27 17727679 Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer. Cancer Sci 2007 Nov 2
28 17908044 Alpha-secretase as a therapeutic target. Curr Alzheimer Res 2007 Sep 3
29 17986385 PI3-K- and PKC-dependent up-regulation of APP processing enzymes by retinoic acid. Biochem Biophys Res Commun 2008 Jan 11 2
30 18036818 Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis. Bioorg Med Chem Lett 2008 Jan 1 1
31 18381078 Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme. Biochim Biophys Acta 2008 Jun 7
32 18420943 ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res 2008 May 23 2
33 18658095 ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. Invest Ophthalmol Vis Sci 2009 Jan 2
34 18952609 Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem 2008 Dec 19 1
35 19091752 Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2. J Biol Chem 2009 Feb 6 1
36 19144697 Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J 2009 Jun 10
37 19183255 A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10. J Neurochem 2009 Mar 1
38 19411314 Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am J Physiol Lung Cell Mol Physiol 2009 Jul 2
39 19432809 CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver. J Cell Mol Med 2009 Aug 1
40 19679113 Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein. Brain Res 2009 Nov 3 1
41 19715556 Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem J 2009 Oct 23 1
42 19783906 Triptolide: An inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells. Cancer Biol Ther 2009 Nov 11
43 19826051 Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma. Cancer Res 2009 Oct 15 2
44 20015014 Fluorescent substrates useful as high-throughput screening tools for ADAM9. Comb Chem High Throughput Screen 2010 May 1
45 20064929 P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells. J Biol Chem 2010 Mar 5 1
46 20100836 An arginine stretch limits ADAM10 exit from the endoplasmic reticulum. J Biol Chem 2010 Apr 2 2
47 20197648 Improved synthesis of ADAM10 inhibitor GI254023X. Neurodegener Dis 2010 2
48 20413873 Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis. J Alzheimers Dis 2010 3
49 20530572 Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth. J Cell Sci 2010 Jul 1 1
50 20595051 Cryptotanshinione upregulates alpha-secretase by activation PI3K pathway in cortical neurons. Brain Res 2010 Aug 12 5